Marlborough, MA, United States of America

Mark David Roberts

This inventor holds 1 USPTO granted patent. Top assignee: Cytiva Sweden Ab. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark David Roberts: Innovator in Perfusion Systems

Introduction

Mark David Roberts is an accomplished inventor based in Marlborough, MA (US). He has made significant contributions to the field of bioprocessing, particularly in the operation of perfusion systems. His innovative approach has led to the development of a unique method that enhances the efficiency of fluid separation in bioreactors.

Latest Patents

Mark holds a patent for a "Method of operation of a perfusion system." This method involves inducing a first quantity of a feed fluid to flow from a bioreactor to a tangential flow filter. The process separates the feed fluid into permeate and retentate fluids. The control unit is designed to manage the flow of the feed fluid, ensuring optimal operation of the system.

Career Highlights

Mark is currently employed at Cytiva Sweden Ab, where he continues to innovate in the field of bioprocessing. His work focuses on improving the efficiency and effectiveness of bioreactor systems. With a patent portfolio that includes 1 patent, he has established himself as a key player in his area of expertise.

Collaborations

Mark collaborates with talented professionals such as Victor Jose and Prashanth Hosabettu Mohan. Together, they work on advancing technologies that support bioprocessing and enhance the capabilities of perfusion systems.

Conclusion

Mark David Roberts is a notable inventor whose work in perfusion systems has the potential to transform bioprocessing. His innovative methods and collaborations with skilled colleagues position him as a leader in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…